HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Europe Business Strategies Deals

EU Business Round-Up: BioGaia Seeks Bigger Slice Of UK, Acino Gets Middle East Backers, Boots Moves Into Advertising

  • News

Executive Summary

The latest European consumer health business news: BioGaia to distribute full probiotics portfolio in the UK; UAE's ADQ snaps up Switzerland's Acino; and Boots launches a personalized ad offering in the UK.

You may also be interested in...



Sweden's BioGaia Grows Share In Latin America As Europe Struggles

BioGaia is now the market leader in Brazil's probiotics category, and has taken second position in the wider Latin American region, thanks to strong growth in the first half of 2021.

EU Business Round-Up: Unilever Steps Up Sustainability, BioGaia Makes Finnish Move, Monat Heads To Spain

The latest EU business news: Unilever unveils planned switch to sustainable toothpaste tubes; BioGaia takes back distribution in key market Finland; and Monat continues its European expansion into Spain and Lithuania.

EU Business Round-Up: Gilbert Grabs Grimberg, Navamedic Adds Brain Health Probiotic, Acino Acquires Russian Portfolio

Latest European consumer health business news: Laboratoires Gilbert strengthens its position in France with Grimberg acquisition; Norway's Navamedic secures distribution of brain health probiotic; and Switzerland's Acino gains two supplements popular in Russia.

Table

View full table

Related Content

HBW Insight

Topics

Tags:
Europe Business Strategies Deals
UsernamePublicRestriction

Register

RS151777

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By